Viking Therapeutics
VKTX
#2507
Rank
C$8.03 B
Marketcap
$72.13
Share price
0.19%
Change (1 day)
363.81%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -C$0.14 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$0.12 Billion a decrease over its 2022 earnings that were of -C$96.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.14 Billion11.54%
2023 -C$0.12 Billion24.73%
2022 -C$96.21 Million25.24%
2021 -C$76.82 Million39.23%
2020 -C$55.18 Million53.21%
2019 -C$36.02 Million16.84%
2018 -C$30.83 Million7.22%
2017 -C$28.75 Million39.68%
2016 -C$20.58 Million-37.05%
2015 -C$32.7 Million6.94%
2014 -C$30.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.73 Billion 424.51%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.25 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.97 M-121.64%๐Ÿ‡บ๐Ÿ‡ธ USA